A new breast screening programme–an audit of the first year

Kirby, Robert; Williams, Marc; Hopper, Graeme P.; Skinner, Megan; French, C.; Súarez, Vianed Marsán; Summerly, M. E.; Gray, J. G.

doi:10.1136/pgmj.67.783.36

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…North Staffordshire has a population of 234,268 females. Breast screening commenced in North Staffordshire in 1988 [ 3 ]. The population of North Staffordshire is recognised as being one of the poorer populations within Britain.…”

Section: Introductionmentioning

confidence: 99%

Patient choice significantly affects mastectomy rates in the treatment of breast cancer

Kirby¹,

Basit

Manimaran

2008

Int Semin Surg Oncol

View full text Add to dashboard Cite

Mastectomy rates may be affected by patient choice. 203 patients who had a Total Mastectomy for breast cancer were invited to complete questionnaires at routine follow up clinics to ascertain if they had been offered a choice of Breast Conserving Surgery (BCS), and to establish the reasons for their preference. Questionnaires were checked against medical and nursing records to confirm the reasons for the patients' choice of mastectomy. 130 patients (64%) chose to have a mastectomy, reporting that they felt safer (n = 119); wanted to decrease the risk of further surgery (n = 87) and/or wished to avoid radiotherapy (n = 34). Some were advised not to have BCS if they had a large tumour size, central or multifocal tumours and/or associated extensive microcalcification on mammography (n = 29). 24 patients had BCS as first operation but had repeat surgery for involved or narrow excision margins. Despite being advised that there is no difference between survival rates of this and breast conserving surgery, many patients still feel safer with mastectomy.

show abstract

Section: Introductionmentioning

confidence: 99%

Patient choice significantly affects mastectomy rates in the treatment of breast cancer

Kirby¹,

Basit

Manimaran

2008

Int Semin Surg Oncol

View full text Add to dashboard Cite

show abstract

Is it time to reposition vasopressors and inotropes in sepsis?

Rudis

Basha

Zarowitz

1996

Critical Care Medicine

View full text Add to dashboard Cite

Insufficient evidence exists to support goal-directed therapy with vasopressors and inotropes in the treatment of sepsis syndrome. No definitive recommendations can be made about the superiority of a vasopressor or inotropic agent due to the lack of data. However, it may be that evaluation of vasopressors earlier in sepsis syndrome will yield more promising results. Large, comparative, controlled trials assessing mortality rate and development of multiple organ system dysfunction are needed.

show abstract

A new breast screening programme–an audit of the first year

Abstract: Summary:The experience ofa new breast screening unit is reported.

Cited by 2 publications

References 3 publications

Patient choice significantly affects mastectomy rates in the treatment of breast cancer

Patient choice significantly affects mastectomy rates in the treatment of breast cancer

Is it time to reposition vasopressors and inotropes in sepsis?

Contact Info

Product

Resources

About